Congratulations to our collaborators, Dr. Xiao He, Dr. Hong Zhang and Dr. Mei Tian! This cutting-edge and delegate study of iPSC-derived forebrain neural progenitor cell hNPC01 was published in Nature Communications on June 3^rd and supported that hNPC01 progeny cells integrated into rat neural circuits. Moreover, the phase 1 clinical study of hNPC01 injection treating chronic ischemic stroke is about to complete 12-months observation of all subjects by the end of June, with IND clearance from NMPA and FDA in 2023 and 2024. Dr. Jing Fan, the founder of Hopstem, will present the exciting clinical data of hNPC01 at the upcoming Bio Congress in Boston, in Room 153C at 11:45 a.m. on June 17. If you are interested in collaboration on RMAT innovative iPSC cell therapy targeting chronic stroke and other CNS diseases, please talk to Dr. Fan at Bio or feel free to contact us online.

Link of publication: https://www.nature.com/articles/s41467-025-60187-5